Krka's Revenues Up in 2011, Profit Down
Novo Mesto, 19 January - The pharmaceutical group Krka generated EUR 1.075bn in revenues in 2011, which is 6% more than in the year before. However, the group's net profit was down to EUR 162m, according to unaudited data released by the Novo mesto-based company on Thursday.
Novo mesto
CEO of drug maker Krka Jože Colarič talking to the press.
Photo: Rasto Božič/STA
Novo mesto
CEO of drug maker Krka Jože Colarič talking to the press.
Photo: Rasto Božič/STA
Novo mesto
CEO of drug maker Krka Jože Colarič talking to the press.
Photo: Rasto Božič/STA
The rest of this news item is available to subscribers.
The news item consists of 1.444 characters (without spaces) or 301 word words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.